Accession Number : AD1011790


Title :   Targeting Premalignant Lesions: Implications for Early Breast Cancer Detection and Intervention


Descriptive Note : Technical Report,01 Apr 2015,31 Mar 2016


Corporate Author : Sanford Burnham Medical Research Institute La Jolla United States


Personal Author(s) : Mann,Aman


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1011790.pdf


Report Date : 01 Apr 2016


Pagination or Media Count : 8


Abstract : Breast cancer progression constitutes a multistep process through a series of intermediate hyperplastic and neoplastic stages to invasive carcinoma. In this study, we aimed to identify peptides that specifically recognize premalignant lesions in the mammary tissue. To achieve this goal, we utilized the power of phage display to probe hyperplastic lesions associated with premalignant disease in a transgenic MMTV-PyMT animal model. We have identified a peptide CISQ that targets to the stroma in premalignant lesions and binds to cancer-associated fibroblasts (CAFs) in MMTV-PyMT mice. Considerable numbers of CAFs are frequently observed within the tumor-associated stroma of various human cancers, including those of the breast, prostate, lung, colon and pancreas and have been also reported in the premalignant lesions. This peptide could provide us with an opportunity to therapeutically intervene to successfully inhibit or even reverse tumor progression.


Descriptors :   breast cancer , neoplasms , Peptides , intervention , nanomedicine , Lesions


Distribution Statement : APPROVED FOR PUBLIC RELEASE